当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析

国药股份

(600511)

  

流通市值:163.07亿  总市值:222.35亿
流通股本:5.53亿   总股本:7.55亿

国药股份(600511)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润9.91亿元,每股收益1.26元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益1934424.34万元,未分配利润1373512.33万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产3479829.75万元,负债1545405.41万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入25,633,950,652.4612,713,002,292.3850,597,449,788.5738,028,539,709.49
营业总成本24,641,402,034.1112,193,672,811.3848,403,886,743.9336,311,068,962.03
其他经营收益
营业利润1,229,118,756.21600,659,751.032,677,421,914.451,989,261,474.35
利润总额1,226,579,932.03605,877,265.632,653,612,391.51,965,833,872.95
净利润991,483,406.86485,061,196.662,129,780,565.041,574,927,175.3
每股收益
其他综合收益337,686.56-84,421.65-3,461,287.34-4,446,206.5
综合收益总额991,821,093.42484,976,775.012,126,319,277.71,570,480,968.8
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计30,259,719,678.3330,442,472,468.1430,356,823,125.0829,770,544,832.57
非流动资产:
非流动资产合计4,538,577,861.624,653,998,605.554,571,456,118.544,565,488,713.99
资产总计34,798,297,539.9535,096,471,073.6934,928,279,243.6234,336,033,546.56
流动负债:
流动负债合计14,382,535,357.6714,549,466,568.7614,855,742,064.9414,617,483,733.64
非流动负债:
非流动负债合计1,071,518,759.231,086,984,438.91,097,493,887.661,262,200,416.65
负债合计15,454,054,116.915,636,451,007.6615,953,235,952.615,879,684,150.29
所有者权益(或股东权益):
归属于母公司股东权益合计17,473,373,453.0117,587,021,750.3917,128,090,785.5216,608,250,755.72
股东权益合计19,344,243,423.0519,460,020,066.0318,975,043,291.0218,456,349,396.27
负债和股东权益合计34,798,297,539.9535,096,471,073.6934,928,279,243.6234,336,033,546.56
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计26,101,716,608.6812,108,689,860.4655,348,362,559.9939,559,819,298.32
经营活动现金流出小计27,612,151,445.4814,001,865,579.3653,689,243,036.1740,589,663,930.41
经营活动产生的现金流量净额-1,510,434,836.8-1,893,175,718.91,659,119,523.82-1,029,844,632.09
投资活动产生的现金流量:
投资活动现金流入小计32,502,299.843,174,950.6447,062,295.4826,469,817.61
投资活动现金流出小计20,579,477.27,353,156.132,630,772,379.16167,968,899.67
投资活动产生的现金流量净额11,922,822.64-4,178,205.49-2,583,710,083.68-141,499,082.06
筹资活动产生的现金流量:
筹资活动现金流入小计160,000,000100,000,000315,981,517.06283,109,437.63
筹资活动现金流出小计1,131,724,433.65226,533,020.571,898,314,943.411,754,026,234.63
筹资活动产生的现金流量净额-971,724,433.65-126,533,020.57-1,582,333,426.35-1,470,916,797
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-2,470,236,447.81-2,023,886,944.96-2,506,923,986.21-2,642,260,511.15
期末现金及现金等价物余额5,821,157,609.156,267,507,1128,291,394,056.968,156,057,532.02
补充资料:
现金及现金等价物的净增加额-2,470,236,447.81--2,506,923,986.21-
最新报告期:2025-08-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华福证券何展聪,陈铁林2.712.883.072025-08-26
华源证券刘闯2.712.873.032025-08-25
中金公司夏璐,张琎,朱言音2.702.88--2025-08-21
华泰证券代雯,孔垂岩,王殷杰2.682.812.942025-08-20
TOP↑